PASADENA, Calif., March 27, 2012
PASADENA, Calif., March 27, 2012 /PRNewswire/ -- Jacobs Engineering Group Inc. (NYSE: JEC) announced today that three of its projects received Facility of the Year Awards (FOYA) from the International Society for Pharmaceutical Engineering (ISPE), INTERPHEX and Pharmaceutical Processing magazine, sponsors of the awards program.
The Vaccine Bulk Manufacturing Facility (VBF) Program of Projects at the Merck facility in Durham, N.C. received the FOYA for Facility Integration. Jacobs provided engineering, procurement, construction management and commissioning/validation services, as well as full modular design and fabrication for the manufacturing facility.
Chiesi Farmaceutici's Research and Development Centre in Parma, Italy won the FOYA for Sustainability. Jacobs executed master planning and laboratory programming, design services, authority application, project and construction management and commissioning for the facility.
The National Institute for Bioprocessing Research and Training (NIBRT) received the FOYA for Special Recognition for Novel Collaboration for its New Greenfield facility in Dublin, Ireland. Jacobs performed concept design, planning application, project management, architecture, process, civil/structural, electrical, BMS, mechanical, building services, contract administration and services during construction for the project.
In making the announcement, Jacobs Group Vice President Bob Pragada stated, "We appreciate the trust our clients have in us to execute their award-winning projects. It is a great honor and privilege to be a valued service provider and a trusted partner to our clients while delivering world class manufacturing and developmental facilities to the industry."
The FOYA program recognizes pharmaceutical manufacturing projects that use new and innovative technologies to enhance project delivery and reduce production costs of high quality medicines for patients worldwide.
Jacobs is one of the world's largest and most diverse providers of technical, professional, and construction services.
Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2011 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.
For additional information contact:Michelle Jones626.578.6968
SOURCE Jacobs Engineering Group Inc.PR Newswire
Last updated on: 27/03/2012
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.